Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models

✍ Scribed by Eugen F. Mesaros; Jason P. Burke; Jonathan D. Parrish; Benjamin J. Dugan; Andrew V. Anzalone; Thelma S. Angeles; Mark S. Albom; Lisa D. Aimone; Matthew R. Quail; Weihua Wan; Lihui Lu; Zeqi Huang; Mark A. Ator; Bruce A. Ruggeri; Mangeng Cheng; Gregory R. Ott; Bruce D. Dorsey

• Book ID: 104005063
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 278 KB
• Volume: 21
• Category: Article
• ISSN: 0960-894X
• DOI: 10.1016/j.bmcl.2010.10.115